Article
The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation.
Blood - 29 Mar 2012
Walasek Marta A, Bystrykh Leonid, van den Boom Vincent, Olthof Sandra, Ausema Albertina, Ritsema Martha, Huls Gerwin, de Haan Gerald, van Os Ronald
Abstract excerpt
Despite increasing knowledge on the regulation of hematopoietic stem/progenitor cell (HSPC) self-renewal and differentiation, in vitro control of stem cell fate decisions has been difficult. The ability to inhibit HSPC commitment in culture may be of benefit to cell therapy protocols. Small molecules can serve as tools to manipulate cell fate decisions. Here, we tested 2 small molecules, valproic acid (VPA) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
